SMTL ID : 5juz.1

Crystal structure of human FPPS in complex with an allosteric inhibitor CL-06-057

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

homo-dimer

Ligands

4 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 3 residues within 4Å: Chain A: D.100, D.102, R.106 Ligand excluded by PLIP CL.2: 4 residues within 4Å: Chain A: K.79, Y.80, N.81, R.82 Ligand excluded by PLIP CL.4: 3 residues within 4Å: Chain B: D.100, D.102, R.106 Ligand excluded by PLIP CL.5: 4 residues within 4Å: Chain B: K.79, Y.80, N.81, R.82 Ligand excluded by PLIP

2 x YL4: [(R)-(2,3-dihydro-1-benzofuran-5-yl){[6-(4-methylphenyl)thieno[2,3-d]pyrimidin-4-yl]amino}methyl]phosphonic acid(Non-covalent)

YL4.3: 11 residues within 4Å: Chain A: G.77, K.79, N.81, T.85, R.135, S.227, F.228, F.261, D.265, L.366, K.369 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:K.79, A:N.81, A:F.228, A:F.228, A:F.261 Water bridges: A:N.81, A:N.81, A:R.82, A:D.265 YL4.6: 11 residues within 4Å: Chain B: G.77, K.79, N.81, T.85, R.135, S.227, F.228, F.261, D.265, L.366, K.369 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:K.79, B:N.81, B:F.228, B:F.228, B:F.261 Water bridges: B:N.81, B:N.81, B:R.82, B:D.265

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Park, J. et al., Pharmacophore Mapping of Thienopyrimidine-Based Monophosphonate (ThP-MP) Inhibitors of the Human Farnesyl Pyrophosphate Synthase. J. Med. Chem. (2017)

Release Date

2017-03-15

Peptides

Farnesyl pyrophosphate synthase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
F

B
F

Farnesyl pyrophosphate synthase

Related Entries With Identical Sequence